Insights
Perspectives on Governance, Accountability & Clinical Development
Kieran Engels writes about the structural patterns that shape clinical development outcomes – and the governance decisions that determine whether programs succeed or fail.
The Age of Accountability
The Age of Accountability resets biotech priorities: clarity of intent, explicit ownership, delivery that matches promise. Speed without control is crash risk. Accountability builds confident acceleration.
Read Article →
-
Building Executional Strength in Clinical Development
Executional strength builds through governance infrastructure. Clear decision rights, accountability, and feedback enable execution.
-
Where Clinical Trial Execution Actually Breaks
Execution breaks in governance gaps, not vendor capability. Clear decision rights, singular accountability, and early feedback prevent delays.
-
Why Execution Is the Real Strategy, What Biotechs and VCs Keep Getting Wrong
Biotech success isn’t about science alone. It’s about execution infrastructure. The companies that get drugs to market fast are the ones with clear governance and…
-
The Speed Trap: When Faster Timelines Create Slower Outcomes in Clinical Development
Speed without control is unmanaged risk. Learn why true acceleration requires clarity of intent, defined decision rights, and explicit tradeoffs in clinical development.